These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Folate and monoamine metabolism in epilepsy. Reynolds EH; Chadwick D; Jenner P; Chanarin I J Neurol Sci; 1975 Dec; 26(4):605-15. PubMed ID: 1206436 [TBL] [Abstract][Full Text] [Related]
84. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels. Leckman JF; Bowers MB; Sturges JS Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366 [TBL] [Abstract][Full Text] [Related]
85. Cerebrospinal fluid probenecid studies: a reinterpretation. Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100 [TBL] [Abstract][Full Text] [Related]
86. A case of amyloidosis associated with diphenylhydantoin therapy. Nomura S; Osawa G; Sato T; Ishimatsu T; Shindo T; Hirano H Jpn J Med; 1989; 28(5):636-9. PubMed ID: 2511368 [TBL] [Abstract][Full Text] [Related]
87. Transient hyperkinesia after a single intravenous perfusion of diphenylhydantoin. Report of a case associated with nontoxic plasma levels of diphenylhydantoin. Mauguière F; Dalery J; de Villard R; Courjon J Eur Neurol; 1979; 18(2):116-23. PubMed ID: 456389 [TBL] [Abstract][Full Text] [Related]